Arrowhead Pharmaceuticals (ARWR) Stock
Arrowhead Pharmaceuticals (ARWR) has a Tenet Score of 33 of 100 against 340 Healthcare peers, as of Nov 16, 2026.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Market cap
- $6.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 37.06 – 95.49
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 33/100
- Weak · 340 Healthcare peers
Industry: Drugs
Arrowhead Pharmaceuticals Inc. scores 33/100. Weak. Value is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for th…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Rhythm Pharmaceuticals Inc.RYTM | 36 | $7.5B |
| Cytokinetics IncCYTK | 34 | $7.4B |
| Kiniksa Pharmaceuticals International Plc.KNSA | 55 | $7.4B |
| Amneal Pharmaceuticals IncAMRX | 39 | $7.4B |
| Axsome Therapeutics IncAXSM | 31 | $7.2B |
| Twist Bioscience CorpTWST | 48 | $7.2B |
| Oruka Therapeutics Inc.ORKA | 54 | $6.7B |
| Belite Bio IncBLTE | 55 | $6.4B |
| ImmunityBio IncIBRX | 51 | $6.4B |
| Ligand Pharmaceuticals, Inc.LGND | 40 | $6.0B |
Common questions
What sector and industry is Arrowhead Pharmaceuticals in?
Arrowhead Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Arrowhead Pharmaceuticals' Tenet Score?
Arrowhead Pharmaceuticals' Tenet Score is 33 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




